These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 11289568)
1. Vardenafil increases penile rigidity and tumescence in erectile dysfunction patients: a RigiScan and pharmacokinetic study. Klotz T; Sachse R; Heidrich A; Jockenhövel F; Rohde G; Wensing G; Horstmann R; Engelmann R World J Urol; 2001 Feb; 19(1):32-9. PubMed ID: 11289568 [TBL] [Abstract][Full Text] [Related]
2. Vardenafil increases penile rigidity and tumescence in men with erectile dysfunction after a single oral dose. Stark S; Sachse R; Liedl T; Hensen J; Rohde G; Wensing G; Horstmann R; Schrott KM Eur Urol; 2001 Aug; 40(2):181-8; discussion 189-90. PubMed ID: 11528196 [TBL] [Abstract][Full Text] [Related]
3. Vardenafil: a review of its use in erectile dysfunction. Keating GM; Scott LJ Drugs; 2003; 63(23):2673-703. PubMed ID: 14636086 [TBL] [Abstract][Full Text] [Related]
4. Vardenafil: a novel type 5 phosphodiesterase inhibitor for the treatment of erectile dysfunction. Kendirci M; Bivalacqua TJ; Hellstrom WJ Expert Opin Pharmacother; 2004 Apr; 5(4):923-32. PubMed ID: 15102574 [TBL] [Abstract][Full Text] [Related]
5. The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease. Thadani U; Smith W; Nash S; Bittar N; Glasser S; Narayan P; Stein RA; Larkin S; Mazzu A; Tota R; Pomerantz K; Sundaresan P J Am Coll Cardiol; 2002 Dec; 40(11):2006-12. PubMed ID: 12475462 [TBL] [Abstract][Full Text] [Related]
6. Vardenafil improved patient satisfaction with erectile hardness, orgasmic function and sexual experience in men with erectile dysfunction following nerve sparing radical prostatectomy. Nehra A; Grantmyre J; Nadel A; Thibonnier M; Brock G J Urol; 2005 Jun; 173(6):2067-71. PubMed ID: 15879836 [TBL] [Abstract][Full Text] [Related]
7. Vardenafil improves erectile function in men with erectile dysfunction irrespective of disease severity and disease classification. Donatucci C; Eardley I; Buvat J; Gittelman M; Kell P; Segerson T; Homering M; Montorsi F; J Sex Med; 2004 Nov; 1(3):301-9. PubMed ID: 16422960 [TBL] [Abstract][Full Text] [Related]
8. Effect of high-fat breakfast and moderate-fat evening meal on the pharmacokinetics of vardenafil, an oral phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction. Rajagopalan P; Mazzu A; Xia C; Dawkins R; Sundaresan P J Clin Pharmacol; 2003 Mar; 43(3):260-7. PubMed ID: 12638394 [TBL] [Abstract][Full Text] [Related]
9. Vardenafil (Levitra) for erectile dysfunction: a systematic review and meta-analysis of clinical trial reports. Markou S; Perimenis P; Gyftopoulos K; Athanasopoulos A; Barbalias G Int J Impot Res; 2004 Dec; 16(6):470-8. PubMed ID: 15229625 [TBL] [Abstract][Full Text] [Related]
10. Improvement in duration of erection following phosphodiesterase type 5 inhibitor therapy with vardenafil in men with erectile dysfunction: the ENDURANCE study. Rosenberg MT; Adams PL; McBride TA; Roberts JN; McCallum SW Int J Clin Pract; 2009 Jan; 63(1):27-34. PubMed ID: 19125990 [TBL] [Abstract][Full Text] [Related]
11. [Levitra (vardenafil)--a new PDE 5 inhibitor for the treatment of erectile dysfunction]. Katsarov M Akush Ginekol (Sofiia); 2004; 43 Suppl 1():31-2. PubMed ID: 15323315 [No Abstract] [Full Text] [Related]
12. Vardenafil. Young JM Expert Opin Investig Drugs; 2002 Oct; 11(10):1487-96. PubMed ID: 12387708 [TBL] [Abstract][Full Text] [Related]
13. Vardenafil--PDE5 inhibitor number 3. Jackson G Int J Clin Pract; 2004 Mar; 58(3):229. PubMed ID: 15117087 [No Abstract] [Full Text] [Related]
15. Vardenafil: a new approach to the treatment of erectile dysfunction. Hellstrom WJ Curr Urol Rep; 2003 Dec; 4(6):479-87. PubMed ID: 14622502 [TBL] [Abstract][Full Text] [Related]
16. New phosphodiesterase type 5 inhibitors in the management of erectile dysfunction. Mason RG J R Soc Promot Health; 2003 Jun; 123(2):79-80. PubMed ID: 12852189 [No Abstract] [Full Text] [Related]
17. Cardiovascular parameter changes in patients with erectile dysfunction using pde-5 inhibitors: a study with sildenafil and vardenafil. Pomara G; Morelli G; Pomara S; Taddei S; Ghiadoni L; Dinelli N; Travaglini F; Dicuio M; Mondaini N; Salvetti A; Selli C J Androl; 2004; 25(4):625-9. PubMed ID: 15223851 [TBL] [Abstract][Full Text] [Related]
18. Duration of erection: does it really matter? A randomized, double-blind clinical trial to assess the impact of vardenafil ODT on duration of erection and its correlation with patients' and partners' sexual quality of life and duration of intercourse: the VADEOPEN study. Martin-Morales A; Gutiérrez-Hernández P; Romero-Otero J; Romero-Martín JA; J Sex Med; 2014 Jun; 11(6):1527-38. PubMed ID: 24628736 [TBL] [Abstract][Full Text] [Related]
19. The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil. Saenz de Tejada I; Angulo J; Cuevas P; Fernández A; Moncada I; Allona A; Lledó E; Körschen HG; Niewöhner U; Haning H; Pages E; Bischoff E Int J Impot Res; 2001 Oct; 13(5):282-90. PubMed ID: 11890515 [TBL] [Abstract][Full Text] [Related]
20. [Pharmacodynamics and pharmacokinetics of vardenafil in patients with erectile dysfunction]. Jin J; Guo Y Zhonghua Nan Ke Xue; 2004 Sep; 10(9):711-6. PubMed ID: 15497717 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]